Performance analysis of Luminex and ELISA to profile serum IP-10 as a biomarker in systemic lupus erythematosus.

Fernanda Espinosa-BautistaDania CoronelVarna Ramos-RosilloLuis M Amezcua Guerra

Published in: Lupus (2022)

Luminex performs better than hs-ELISA as a quantification platform for IP-10 as it correlates with disease activity and identifies active arthritis in SLE.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
monoclonal antibody
genome wide
high throughput
gene expression